Selected article for: "early study and morbidity disease"

Author: Alhoufie, Sari T.; Alsharif, Naif H.; Alfarouk, Khalid O.; Ibrahim, Nadier A.; Kheyami, Ali M.; Aljifri, Alanoud A.
Title: COVID-19 with Underdiagnosed influenza B and parainfluenza-2 co-infections in Saudi Arabia: Two case reports
  • Cord-id: zu4ys0mn
  • Document date: 2021_9_15
  • ID: zu4ys0mn
    Snippet: The emerging of the COVID-19 pandemic is currently challenging for the public health system globally. Beyond SARS-CoV-2 pathogenicity, co-infections with recycling respiratory pathogens, whether bacterial, viral, or fungal, might increase disease symptoms, morbidity, and mortality. In this study, we reported two COVID-19 cases in the early phase of the virus spread in Saudi Arabia with underdiagnosed respiratory viruses’ co-infections, influenza B and Parainfluenza-2, detected retrospectively.
    Document: The emerging of the COVID-19 pandemic is currently challenging for the public health system globally. Beyond SARS-CoV-2 pathogenicity, co-infections with recycling respiratory pathogens, whether bacterial, viral, or fungal, might increase disease symptoms, morbidity, and mortality. In this study, we reported two COVID-19 cases in the early phase of the virus spread in Saudi Arabia with underdiagnosed respiratory viruses’ co-infections, influenza B and Parainfluenza-2, detected retrospectively. Fortunately, both patients recovered and were discharged home. Underestimation of co-infection among COVID19 patients might lead to hospital stay prolongation and increases morbidity and mortality. Therefore, it is crucial to consider and screen for co-infecting pathogens among COVID-19 patients and those with risk factors.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory ards distress syndrome and additional administration: 1
    • acute respiratory ards distress syndrome and admission time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory ards distress syndrome and lupus erythematosus: 1, 2, 3, 4, 5, 6, 7
    • administered medication and lupus erythematosus: 1
    • admission time and lung opacity: 1, 2
    • lung opacity and lupus erythematosus: 1
    • lupus erythematosus and lysosomal membrane: 1